Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Accuracy of 3D Electrical Impedance Tomography for Assessing Lung Ventilation

4 agosto 2026 aggiornato da: Shanghai Zhongshan Hospital

Accuracy of Three-Dimensional Electrical Impedance Tomography for Assessing Dynamic Regional Lung Ventilation Validated by Four-Dimensional CT: A Prospective Observational Study

This prospective observational study will evaluate how accurately three-dimensional electrical impedance tomography (3D-EIT) measures the distribution of air in the lungs during breathing when compared with four-dimensional computed tomography (4D-CT).

3D-EIT is a noninvasive, radiation-free imaging method that measures changes in electrical impedance across the chest and can provide continuous information about regional lung ventilation. In this study, 4D-CT will be used as the reference method because it can provide detailed images of changes in the lungs throughout the breathing cycle.

Approximately 50 adults, including healthy volunteers and hospitalized patients who are able to undergo both examinations, will be enrolled at a single center. EIT and CT data will be collected at the same time during stable breathing. Researchers will compare the two methods to determine how closely their measurements of ventilation in different lung regions agree. The study will also explore whether EIT can detect changes in regional ventilation under different breathing conditions.

The study will not use the research EIT results to make clinical treatment decisions. The findings may support the future use of EIT as a noninvasive, radiation-free method for monitoring regional lung ventilation.

Panoramica dello studio

Tipo di studio

Osservativo

Iscrizione (Stimato)

50

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Adulto
  • Adulto più anziano

Accetta volontari sani

Sì

Metodo di campionamento

Campione non probabilistico

Popolazione di studio

The study population will include adults aged 18 years or older recruited at the Department of Critical Care Medicine, Zhongshan Hospital, Fudan University. Participants will consist of healthy volunteers and intensive care unit patients for whom CT imaging is considered necessary based on the treating physician's clinical judgment. Eligible participants must be able to undergo simultaneous 4D-CT and 3D-EIT monitoring.

This is a prospective, observational, single-center study. Participation will not alter the participant's routine clinical management, and the research-derived three-dimensional EIT reconstruction results will not be used directly to make clinical treatment decisions.

Descrizione

Inclusion Criteria:

  • Age 18 years or older.
  • Healthy volunteers or patients in the intensive care unit for whom CT imaging is considered necessary based on the treating physician's clinical judgment.
  • Able to cooperate with or undergo simultaneous 4D-CT and 3D-EIT monitoring.
  • Able to provide written informed consent personally or through a legally authorized representative, as applicable.

Exclusion Criteria:

  • Unable to tolerate or having a contraindication to 4D-CT examination, including pregnancy or severe respiratory distress.
  • Extensive chest skin injury or infection, or any condition preventing placement of the EIT electrode belt.
  • Body size or chest deformity that may substantially limit the quality of EIT or CT data, including chest circumference outside the compatible range of the EIT device.
  • Presence of an implanted electronic device that may interfere with EIT signals, such as a cardiac pacemaker.
  • Unable to complete simultaneous 4D-CT and 3D-EIT monitoring because of significant motion, persistent coughing, poor cooperation, or other technical or clinical reasons.
  • Any other condition that, in the investigator's judgment, makes the individual unsuitable for participation in the study.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

Coorti e interventi

Gruppo / Coorte
Intervento / Trattamento
Paired 3D-EIT and 4D-CT Assessment Cohort
This single cohort will include approximately 50 adults, including healthy volunteers and hospitalized patients, who are able to undergo synchronous 3D-EIT and 4D-CT data acquisition. Regional lung ventilation measurements obtained by the two methods during the same breathing cycle will be compared for agreement and accuracy. Participants will not be assigned to different study groups, and the research EIT results will not be used to direct clinical treatment.
Regional lung ventilation data will be collected using a chest electrical impedance tomography system (V200-S). Electrical impedance changes in the chest will be measured continuously and reconstructed to assess three-dimensional regional ventilation distribution. EIT data will be acquired synchronously with dynamic computed tomography data and will be used for research analysis only. The research EIT results will not directly guide clinical treatment decisions.
Altri nomi:
  • 3D-EIT
Dynamic chest computed tomography data will be acquired using an X-ray computed tomography system (uCT 610 Sim) during one or more breathing cycles. The images will be reconstructed and analyzed to quantify changes in regional lung air volume and ventilation distribution. The 4D-CT measurements will serve as the reference method for comparison with 3D-EIT measurements.
Altri nomi:
  • 4D-TC

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Deming and Passing-Bablok Regression Slopes and Intercepts Comparing Regional Ventilation Fraction Measured by 3D-EIT and 4D-CT
Lasso di tempo: Periprocedural, during synchronous 3D-EIT and 4D-CT acquisition at the study visit; one respiratory cycle is from the onset of one inspiration to the onset of the next.
For each participant, paired regional ventilation fraction measurements obtained by 3D-EIT and 4D-CT during the same synchronized respiratory cycle will be analyzed. Regional ventilation fraction will be expressed as the percentage of total ventilation within each predefined lung region. Prespecified regions may include the ventral and dorsal lung regions, dependent and nondependent regions, and the left and right lungs. Agreement between the two methods will be assessed using Deming regression and Passing-Bablok regression. Regression slopes, intercepts, and their 95% confidence intervals will be reported. A slope closer to 1 and an intercept closer to 0 indicate better agreement between the two methods.
Periprocedural, during synchronous 3D-EIT and 4D-CT acquisition at the study visit; one respiratory cycle is from the onset of one inspiration to the onset of the next.

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Pearson Correlation Coefficient Between Regional Ventilation Fraction Measurements Obtained by 3D-EIT and 4D-CT
Lasso di tempo: Periprocedural, during the synchronous 3D-EIT and 4D-CT acquisition at the study visit
Paired regional ventilation fraction measurements obtained from spatially and temporally aligned 3D-EIT and 4D-CT ventilation data will be evaluated using the Pearson correlation coefficient. Regional ventilation fraction will be expressed as the percentage of total ventilation within each predefined lung region. Analyses will be performed for predefined regions, including the ventral and dorsal regions, left and right lungs, and dependent and nondependent regions, as applicable. Pearson correlation coefficients and their 95% confidence intervals will be reported.
Periprocedural, during the synchronous 3D-EIT and 4D-CT acquisition at the study visit
Mean Bias and 95% Limits of Agreement Between Regional Ventilation Fraction Measurements Obtained by 3D-EIT and 4D-CT
Lasso di tempo: Periprocedural, during the synchronous 3D-EIT and 4D-CT acquisition at the study visit
Agreement between paired regional ventilation fraction measurements obtained by 3D-EIT and 4D-CT will be evaluated using Bland-Altman analysis. Regional ventilation fraction will be expressed as the percentage of total ventilation within each predefined lung region. The mean difference between the two methods, corresponding 95% confidence interval, and the lower and upper 95% limits of agreement will be reported.
Periprocedural, during the synchronous 3D-EIT and 4D-CT acquisition at the study visit

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

1 settembre 2026

Completamento primario (Stimato)

31 dicembre 2026

Completamento dello studio (Stimato)

1 luglio 2027

Date di iscrizione allo studio

Primo inviato

30 luglio 2026

Primo inviato che soddisfa i criteri di controllo qualità

4 agosto 2026

Primo Inserito (Effettivo)

10 agosto 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

10 agosto 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

4 agosto 2026

Ultimo verificato

1 agosto 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • B2026-447

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi